Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ERAS

Stock NameErasca Inc
TickerERAS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS29479A1088

Show aggregate ERAS holdings

News associated with ERAS

Erasca (NASDAQ:ERAS) Receives Underperform Rating from Bank of America
Erasca (NASDAQ:ERAS – Get Free Report)‘s stock had its “underperform” rating restated by analysts at Bank of America in a research note issued on Wednesday, Marketbeat reports. They currently have a $1.00 price objective on the stock, down from their prior price objective of $4.00. Bank of America‘s price objective would suggest a potential downside […] - 2025-09-05 05:11:01
Analysts Set Erasca, Inc. (NASDAQ:ERAS) Target Price at $4.29
Shares of Erasca, Inc. (NASDAQ:ERAS – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The […] - 2025-09-01 03:01:09
Erasca, Inc. (NASDAQ:ERAS) Receives $4.57 Consensus Target Price from Analysts
Erasca, Inc. (NASDAQ:ERAS – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are currently covering the company, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock in the last […] - 2025-08-07 02:13:04
TD Asset Management Inc Purchases 15,286 Shares of Erasca, Inc. (NASDAQ:ERAS)
TD Asset Management Inc lifted its stake in Erasca, Inc. (NASDAQ:ERAS – Free Report) by 6.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 256,032 shares of the company’s stock after acquiring an additional 15,286 shares during the period. TD Asset […] - 2025-08-05 05:02:47
Teacher Retirement System of Texas Reduces Stock Position in Erasca, Inc. (NASDAQ:ERAS)
Teacher Retirement System of Texas lowered its holdings in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 16.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 45,790 shares of the company’s stock after selling 8,916 shares during the quarter. […] - 2025-07-22 04:14:57
Erasca, Inc. (NASDAQ:ERAS) Stock Holdings Lowered by Alps Advisors Inc.
Alps Advisors Inc. decreased its holdings in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 8.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 210,283 shares of the company’s stock after selling 18,336 shares during the period. Alps Advisors Inc.’s holdings in Erasca were worth $288,000 at the end of the most recent […] - 2025-07-18 04:49:06
Erasca, Inc. (NASDAQ:ERAS) Receives Consensus Recommendation of “Buy” from Brokerages
Erasca, Inc. (NASDAQ:ERAS – Get Free Report) has earned an average recommendation of “Buy” from the seven research firms that are presently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have covered the stock in the last year is […] - 2025-07-10 05:49:00
Analysts Set Erasca, Inc. (NASDAQ:ERAS) Price Target at $4.57
Erasca, Inc. (NASDAQ:ERAS – Get Free Report) has earned a consensus recommendation of “Buy” from the seven ratings firms that are covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have issued ratings on the stock in the last […] - 2025-06-18 02:07:00
Nuveen Asset Management LLC Has $1.40 Million Stock Holdings in Erasca, Inc. (NASDAQ:ERAS)
Nuveen Asset Management LLC grew its position in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 14.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 555,704 shares of the company’s stock after acquiring an additional 72,121 shares during the […] - 2025-06-04 04:40:48
Janus Henderson Group PLC Sells 4,036,348 Shares of Erasca, Inc. (NASDAQ:ERAS)
Janus Henderson Group PLC cut its position in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 98.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 73,200 shares of the company’s stock after selling 4,036,348 shares during the quarter. Janus Henderson Group PLC’s holdings in Erasca were worth $184,000 as of its […] - 2025-05-26 04:44:50
Erasca, Inc. (NASDAQ:ERAS) Receives Consensus Recommendation of “Buy” from Brokerages
Erasca, Inc. (NASDAQ:ERAS – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have updated their coverage on the stock in the last […] - 2025-05-21 04:32:48
MetLife Investment Management LLC Buys 9,039 Shares of Erasca, Inc. (NASDAQ:ERAS)
MetLife Investment Management LLC increased its stake in Erasca, Inc. (NASDAQ:ERAS – Free Report) by 8.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 112,725 shares of the company’s stock after purchasing an additional 9,039 shares during the period. MetLife Investment Management LLC’s holdings in […] - 2025-05-08 05:02:47
Invesco Ltd. Buys 11,290 Shares of Erasca, Inc. (NASDAQ:ERAS)
Invesco Ltd. boosted its position in Erasca, Inc. (NASDAQ:ERAS – Free Report) by 30.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 48,671 shares of the company’s stock after purchasing an additional 11,290 shares during the period. Invesco Ltd.’s holdings in Erasca were worth $122,000 at the end of the most recent […] - 2025-05-06 05:12:45
Erasca, Inc. (NASDAQ:ERAS) Shares Purchased by Barclays PLC
Barclays PLC raised its stake in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 9.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 377,764 shares of the company’s stock after acquiring an additional 33,834 shares during the quarter. Barclays PLC’s holdings in […] - 2025-05-06 05:12:45
Renaissance Technologies LLC Has $2.84 Million Holdings in Erasca, Inc. (NASDAQ:ERAS)
Renaissance Technologies LLC trimmed its holdings in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 12.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,133,000 shares of the company’s stock after selling 158,000 shares during the period. Renaissance Technologies LLC owned approximately 0.40% of […] - 2025-04-25 05:54:48
Erasca, Inc. (NASDAQ:ERAS) Holdings Increased by Geode Capital Management LLC
Geode Capital Management LLC increased its stake in Erasca, Inc. (NASDAQ:ERAS – Free Report) by 1.5% in the 4th quarter, HoldingsChannel reports. The fund owned 4,569,819 shares of the company’s stock after acquiring an additional 67,121 shares during the period. Geode Capital Management LLC’s holdings in Erasca were worth $11,474,000 at the end of the […] - 2025-04-23 04:26:59
Wellington Management Group LLP Invests $1.17 Million in Erasca, Inc. (NASDAQ:ERAS)
Wellington Management Group LLP purchased a new stake in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor purchased 465,672 shares of the company’s stock, valued at approximately $1,169,000. Several other large investors have also made changes to their positions in the company. Barclays PLC lifted its […] - 2025-04-14 05:27:01
Head-To-Head Contrast: Erasca (NASDAQ:ERAS) and Merck KGaA (OTCMKTS:MKGAF)
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) and Erasca (NASDAQ:ERAS – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk. Analyst Ratings This is a breakdown of current ratings […] - 2025-04-10 03:07:11
Erasca (NASDAQ:ERAS) Coverage Initiated at Raymond James
Equities research analysts at Raymond James started coverage on shares of Erasca (NASDAQ:ERAS – Get Free Report) in a research note issued on Wednesday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $5.00 price target on the stock. Raymond James’ price target indicates a potential upside of 222.58% from the stock’s previous […] - 2025-03-28 04:52:43
Intech Investment Management LLC Purchases 34,083 Shares of Erasca, Inc. (NASDAQ:ERAS)
Intech Investment Management LLC increased its holdings in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 53.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 97,369 shares of the company’s stock after buying an additional 34,083 shares during the quarter. Intech Investment Management […] - 2025-03-27 06:28:55
Bank of New York Mellon Corp Increases Stake in Erasca, Inc. (NASDAQ:ERAS)
Bank of New York Mellon Corp boosted its position in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 6.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 544,819 shares of the company’s stock after purchasing an additional 35,268 shares during the period. Bank of New York Mellon Corp’s holdings in Erasca were worth […] - 2025-03-24 06:22:47
Erasca (NASDAQ:ERAS) Price Target Lowered to $3.00 at The Goldman Sachs Group
Erasca (NASDAQ:ERAS – Free Report) had its price target trimmed by The Goldman Sachs Group from $3.50 to $3.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other research firms also recently issued reports on ERAS. Bank of America upgraded Erasca from […] - 2025-03-24 04:12:55
Reviewing Erasca (NASDAQ:ERAS) & Allakos (NASDAQ:ALLK)
Erasca (NASDAQ:ERAS – Get Free Report) and Allakos (NASDAQ:ALLK – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability. Profitability This table compares Erasca and Allakos’ net margins, […] - 2025-02-05 04:06:46

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ERAS holdings

DateNumber of ERAS Shares HeldBase Market Value of ERAS SharesLocal Market Value of ERAS SharesChange in ERAS Shares HeldChange in ERAS Base ValueCurrent Price per ERAS Share HeldPrevious Price per ERAS Share Held
2025-11-11 (Tuesday)194,883USD 459,924USD 459,924
2025-11-10 (Monday)194,883ERAS holding increased by 505USD 446,282ERAS holding increased by 5044USD 446,282505USD 5,044 USD 2.29 USD 2.27
2025-11-07 (Friday)194,378USD 441,238ERAS holding increased by 5831USD 441,2380USD 5,831 USD 2.27 USD 2.24
2025-11-06 (Thursday)194,378ERAS holding increased by 506USD 435,407ERAS holding increased by 8889USD 435,407506USD 8,889 USD 2.24 USD 2.2
2025-11-05 (Wednesday)193,872USD 426,518ERAS holding decreased by -21326USD 426,5180USD -21,326 USD 2.2 USD 2.31
2025-11-04 (Tuesday)193,872ERAS holding increased by 508USD 447,844ERAS holding decreased by -12362USD 447,844508USD -12,362 USD 2.31 USD 2.38
2025-11-03 (Monday)193,364USD 460,206ERAS holding decreased by -7735USD 460,2060USD -7,735 USD 2.38 USD 2.42
2025-10-31 (Friday)193,364USD 467,941ERAS holding decreased by -7734USD 467,9410USD -7,734 USD 2.42 USD 2.46
2025-10-30 (Thursday)193,364ERAS holding increased by 2540USD 475,675ERAS holding increased by 25330USD 475,6752,540USD 25,330 USD 2.46 USD 2.36
2025-10-29 (Wednesday)190,824ERAS holding increased by 1016USD 450,345ERAS holding decreased by -12787USD 450,3451,016USD -12,787 USD 2.36 USD 2.44
2025-10-28 (Tuesday)189,808USD 463,132ERAS holding increased by 9491USD 463,1320USD 9,491 USD 2.44 USD 2.39
2025-10-27 (Monday)189,808USD 453,641ERAS holding increased by 1898USD 453,6410USD 1,898 USD 2.39 USD 2.38
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ERAS by Blackrock for IE00BYXG2H39

Show aggregate share trades of ERAS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY5052.4102.280 2.293USD 1,158 1.81
2025-11-06BUY5062.2902.150 2.164USD 1,095 1.81
2025-11-04BUY5082.3802.220 2.236USD 1,136 1.80
2025-10-30BUY2,5402.5402.340 2.360USD 5,994 1.80
2025-10-29BUY1,0162.3602.480 2.468USD 2,507 1.79
2025-10-22SELL-2,0202.2702.410 2.396USD -4,840 1.78 Loss of -1,250 on sale
2025-10-20BUY1,0102.4602.505 2.501USD 2,526 1.77
2025-10-17BUY2,5202.4202.550 2.537USD 6,393 1.77
2025-10-15BUY4,0082.4902.540 2.535USD 10,160 1.76
2025-10-03BUY3,5702.4202.645 2.622USD 9,362 1.76
2025-10-02BUY5092.1302.320 2.301USD 1,171 1.75
2025-09-30BUY1,0182.1802.310 2.297USD 2,338 1.75
2025-09-26BUY1,0222.0802.120 2.116USD 2,163 1.74
2025-09-25BUY1,0221.8101.910 1.900USD 1,942 1.74
2025-09-24BUY11.9101.940 1.937USD 2 1.74
2025-09-18BUY5201.8701.870 1.870USD 972 1.74
2025-09-17BUY1,5601.6701.800 1.787USD 2,788 1.74
2025-08-20SELL-2,0441.4601.530 1.523USD -3,113 1.75 Profit of 458 on sale
2025-07-30BUY2,0201.5501.595 1.591USD 3,213 1.75
2025-07-17SELL-1,0141.4901.515 1.512USD -1,534 1.76 Profit of 254 on sale
2025-07-11SELL-4,0961.4501.540 1.531USD -6,271 1.77 Profit of 986 on sale
2025-07-07BUY1,5361.4201.490 1.483USD 2,278 1.78
2025-07-02BUY28,2151.4501.510 1.504USD 42,435 1.78
2025-06-11BUY1,0321.5201.615 1.606USD 1,657 1.81
2025-06-10BUY1,0321.6101.675 1.668USD 1,722 1.81
2025-06-04SELL-5191.5301.585 1.580USD -820 1.81 Profit of 122 on sale
2025-04-23BUY5141.4201.550 1.537USD 790 1.96
2025-04-10SELL-4,1201.0651.150 1.141USD -4,703 2.04 Profit of 3,688 on sale
2025-04-08SELL-5131.0601.280 1.258USD -645 2.06 Profit of 410 on sale
2025-04-07SELL-5141.2251.240 1.239USD -637 2.07 Profit of 426 on sale
2025-04-04SELL-2,6001.1601.205 1.201USD -3,121 2.08 Profit of 2,281 on sale
2025-04-01BUY18,5271.2051.360 1.345USD 24,910 2.10
2025-03-31SELL-1,3891.3701.490 1.478USD -2,053 2.11 Profit of 874 on sale
2025-03-14SELL-7,4241.4401.490 1.485USD -11,025 2.20 Profit of 5,332 on sale
2025-03-07SELL-9281.5301.550 1.548USD -1,437 2.26 Profit of 658 on sale
2025-03-04SELL-4641.3201.340 1.338USD -621 2.30 Profit of 445 on sale
2025-02-25BUY9281.4001.455 1.450USD 1,345 2.38
2025-02-19SELL-4641.5101.550 1.546USD -717 2.45 Profit of 419 on sale
2025-02-13BUY1,3831.6301.650 1.648USD 2,279 2.52
2025-02-12BUY4611.5701.615 1.611USD 742 2.54
2025-02-11BUY1,8401.5801.660 1.652USD 3,040 2.56
2024-12-30SELL-15,4652.5502.575 2.573USD -39,784 2.84 Profit of 4,212 on sale
2024-11-18SELL-7,3832.7302.970 2.946USD -21,750 2.81 Loss of -1,041 on sale
2024-11-08SELL-4923.1403.225 3.216USD -1,583 2.77 Loss of -221 on sale
2024-10-21SELL-4972.7302.920 2.901USD -1,442 0.00 Loss of -1,442 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ERAS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19131,428400302,68543.4%
2025-09-18158,856475468,80333.9%
2025-09-17101,284187416,12824.3%
2025-09-1697,8591,475309,80831.6%
2025-09-15115,8162,065334,29834.6%
2025-09-12114,0520290,99039.2%
2025-09-11119,421500375,44931.8%
2025-09-1097,4930326,96729.8%
2025-09-0951,7260165,31231.3%
2025-09-08180,50130390,85346.2%
2025-09-05378,96301,326,92728.6%
2025-09-04211,1473,812421,56950.1%
2025-09-03793,30729,6351,328,15859.7%
2025-09-0272,3505,000162,27544.6%
2025-08-2986,8082,000217,01040.0%
2025-08-2848,5000136,95035.4%
2025-08-2757,3400124,28446.1%
2025-08-2696,9720177,55254.6%
2025-08-25102,1370191,09453.4%
2025-08-22178,0450367,93048.4%
2025-08-2138,946098,95139.4%
2025-08-2068,4740172,38639.7%
2025-08-1993,8040175,07853.6%
2025-08-1895,8420217,47044.1%
2025-08-15102,0081,900160,67363.5%
2025-08-14202,5850356,75656.8%
2025-08-13182,103479327,63455.6%
2025-08-12170,3890264,55864.4%
2025-08-11139,6630233,94759.7%
2025-08-0891,6550212,62443.1%
2025-08-07114,3430221,90151.5%
2025-08-06111,4820232,05848.0%
2025-08-05117,7580277,41442.4%
2025-08-0489,4600253,99535.2%
2025-08-0190,2147,977343,43126.3%
2025-07-31425,21530,706526,38180.8%
2025-07-3079,3164,057161,97149.0%
2025-07-29214,3843,318471,74945.4%
2025-07-28170,0490305,29055.7%
2025-07-2559,385205152,10039.0%
2025-07-2449,6630225,88722.0%
2025-07-23173,20727,028439,68239.4%
2025-07-22172,2200394,38343.7%
2025-07-2194,0781207,74845.3%
2025-07-1866,5534,000181,44236.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.